Showing posts with label
autoimmune diseases
.
Show all posts
Showing posts with label
autoimmune diseases
.
Show all posts
Tuesday, May 27, 2025
Cabaletta Bio (CABA) is a microcap stock with a serious pipeline in the Healthcare field, and a possible takeover target. Read on...
›
Cabaletta Bio Might See a Takeover Offer in the Near Future Date: May 27, 2025 Ticker: NASDAQ: CABA Sector: Biotechnology Market Ca...
Wednesday, November 27, 2024
Cures for antoimmune diseases such as MD, Lupus, Mytosis MS and others are targets for this cutting edge, Bio Tech microcap!
›
Recent Developments, Nov 18th 2024 Cabaletta Bio, Inc. (Nasdaq: CABA) is a clinical-stage biotechnology company focused on developing engine...
›
Home
View web version
